Abstract: Disclosed is a method that can evaluate the degree of purity of an active pharmaceutical substance contained in a composite body. Also disclosed is a method for producing a composite body in which the degree of purity of an active pharmaceutical substance itself is 95.0% or higher. The method for evaluating purity comprises: a reaction step for reacting, in a polar solvent, a nitrogen-containing nucleophilic agent, such as hydroxylamine, with a composite body in the presence of a protonic acid; and an evaluation step for evaluating, using rapid liquid chromatography, the degree of purity of a reaction mixture obtained in the reaction step. The method for producing a composite body comprises a reaction step for obtaining a composite body by reacting, in a polar solvent, N-(2-hydroxypropyl)methacrylamide polymer with an anthracycline pharmaceutical substance, in the presence of a protonic acid and at 10°C or lower.
| # | Name | Date |
|---|---|---|
| 1 | 202337008454.pdf | 2023-02-09 |
| 2 | 202337008454-STATEMENT OF UNDERTAKING (FORM 3) [09-02-2023(online)].pdf | 2023-02-09 |
| 3 | 202337008454-PROOF OF RIGHT [09-02-2023(online)].pdf | 2023-02-09 |
| 4 | 202337008454-POWER OF AUTHORITY [09-02-2023(online)].pdf | 2023-02-09 |
| 5 | 202337008454-FORM 1 [09-02-2023(online)].pdf | 2023-02-09 |
| 6 | 202337008454-DECLARATION OF INVENTORSHIP (FORM 5) [09-02-2023(online)].pdf | 2023-02-09 |
| 7 | 202337008454-COMPLETE SPECIFICATION [09-02-2023(online)].pdf | 2023-02-09 |
| 8 | 202337008454-certified copy of translation [10-02-2023(online)].pdf | 2023-02-10 |
| 9 | 202337008454-FORM 3 [06-03-2023(online)].pdf | 2023-03-06 |
| 10 | 202337008454-MARKED COPIES OF AMENDEMENTS [23-05-2024(online)].pdf | 2024-05-23 |
| 11 | 202337008454-FORM 13 [23-05-2024(online)].pdf | 2024-05-23 |
| 12 | 202337008454-Annexure [23-05-2024(online)].pdf | 2024-05-23 |
| 13 | 202337008454-AMMENDED DOCUMENTS [23-05-2024(online)].pdf | 2024-05-23 |
| 14 | 202337008454-FORM 18 [24-05-2024(online)].pdf | 2024-05-24 |